Percutaneous Coronary Intervention Market Segmentation By Product (PTCA Catheters, Coronary Stents, Coronary Guidewire & Accessories) and By End Users (Hospitals, Clinics, Ambulatory Surgical Centers and Research & Academic Institutes) - Global Industry Demand Analysis and Opportunity Assessment 2018-2027
Buy Now Report ID: 2386 | Published Date: Feb 09, 2023Percutaneous Coronary Intervention Market
1. INTRODUCTION
· MARKET DEFINITION
· MARKET SEGMENTATION
· PRODUCT OVERVIEW
2. ASSUMPTIONS AND ACRONYMS
3. RESEARCH METHODOLOGY
· RESEARCH PROCESS
· SECONDARY RESEARCH
· PRIMARY RESEARCH
· MARKET SIZE ESTIMATION
4. EXECUTIVE SUMMARY - GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
5. POLICIES AND REGULATIONS
6. ANALYSIS OF MARKET DYNAMICS
6.1. GROWTH DRIVERS
6.2. KEY TRENDS
7. KEY MARKET OPPORTUNITIES
8. MAJOR ROADBLOCKS FOR THE MARKET GROWTH
9. INDUSTRY RISK ANALYSIS
· DEMAND RISK ANALYSIS
· SUPPLY RISK ANALYSIS
10. EVALUATION OF INNOVATIVE TECHNOLOGIES IN CATHETERS USED IN INTERVENTION CARDIOLOGY
11. CLINICAL TRIAL ANALYSIS
12. AVERAGE PRICING ANALYSIS
13. COMPARISON OF DIFFERENT INNOVATIONS USED IN ANGIOPLASTY PROCEDURES
14. EPIDEMIOGY ANALYSIS
· OBSTRUCTIVE CORONARY ARTERY DISEASE
· SPONTANEOUS CORONARY ARTERY DISSECTION (SCAD)
· AGE GROUP OF THE PEOPLE PREFERRING PERCUTANEOUS CORONARY INTERVENTION
15. GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET OUTLOOK
15.1. MARKET SIZE AND FORECAST, 2018-2027
· BY VALUE (USD MILLION)
15.2. GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SEGMENTATION, 2018-2027
15.2.1. BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
15.2.2. BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
16. BY REGION
16.1. NORTH AMERICA PERCUTANEOUS CORONARY INTERVENTION MARKET, 2018-2027F (USD MILLION)
· ASSESSMENT OF MACROECONOMIC FACTORS
· MARKET OVERVIEW
· MARKET SIZE, 2018-2027F (USD MILLION)
· MARKET SEGMENTATION
Ø BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
Ø BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
Ø BY COUNTRY
o US, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
o CANADA, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
16.2. EUROPE PERCUTANEOUS CORONARY INTERVENTION MARKET, 2018-2027F (USD MILLION)
· ASSESSMENT OF MACROECONOMIC FACTORS
· MARKET OVERVIEW
· MARKET SIZE, 2018-2027F (USD MILLION)
· MARKET SEGMENTATION
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
◊ BY COUNTRY
o UK, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
o GERMANY, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
o FRANCE, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
o ITALY, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
o SPAIN, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
o RUSSIA, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
• REST OF EUROPE, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
16.3. ASIA PACIFIC PERCUTANEOUS CORONARY INTERVENTION MARKET, 2018-2027F (USD MILLION)
· ASSESSMENT OF MACROECONOMIC FACTORS
· MARKET OVERVIEW
· MARKET SIZE, 2018-2027F (USD MILLION)
· MARKET SEGMENTATION
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
◊ BY COUNTRY
o CHINA, 2018-2027F (USD MILLION)
◊ BY PRODUCT
· PTCA CATHETERS, CORONARY STENTS, CORONARY GUIDEWIRE AND ACCESSORIES, 2018-2027F (USD MILLION)
o CORONARY STENTS: DRUG-ELUTING STENTS (DES), BARE METAL STENTS AND BIORESORBABLE STENTS, 2018-2027F (USD MILLION)
o ACCESSORIES: INFLATION DEVICES, TORQUER, RHV (Y-CONNECTOR), CONTROL SYRINGE, MANIFOLD AND EXTENSION LINE, 2018-2027F (USD MILLION)
◊ BY END-USERS
· HOSPITALS, CLINICS, AMBULATORY SURGICAL CENTERS AND RESEARCH AND ACADEMIC INSTITUTES, 2018-2027F (USD MILLION)
o INDIA, 2018-2027F (USD MILLION)
By Product
The global percutaneous coronary intervention market has been segmented on the basis of product into PTCA catheters, coronary stents, coronary guidewire and accessories. Coronary stents segment with 53.84% share in the year 2018, occupies the largest market of percutaneous coronary intervention across the globe. Additionally, the coronary stent segment is anticipated to cross USD 12864.93 million by the end of 2027 and is anticipated to flourish at a CAGR of 5.90% over the forecast period. Further, the PTCA catheters segment is estimated to grow with a CAGR of 5.21% over the forecast period.
The global percutaneous coronary intervention market is segmented by regions into North America, Latin America, Europe, Asia-Pacific and Middle East and Africa. Among these regions, the market of North America percutaneous coronary intervention is driven by U.S. and Canada, where U.S. held the dominant market share of around 89% during the year 2018. Improved healthcare infrastructure, increased funds for R&D in healthcare industry along with the growing initiatives taken by the U.S. government to upgrade percutaneous coronary intervention products predicts a significant growth of percutaneous coronary intervention market in upcoming years. Additionally, North America is expected to expand by observing the growth rate of 1.47x over the forecast period, which in turn is estimated to have a positive effect on the demand for percutaneous coronary intervention products in the long run.
Further, Germany, UK, Spain and France are the prominent countries that are driving the growth of the Europe percutaneous coronary intervention market, where Germany accounted for the largest market share of around 23% in the year 2018. Increasing government support in the major countries of Europe along with the increasing healthcare expenditure of the nation in the region and the rising demand for cardiovascular surgeries amongst the ageing population signifies the growth in Europe percutaneous coronary intervention market.
Europe is expected to observe the growth rate of 1.41x over the forecast period and achieve Y-o-Y growth rate of 5.67% in 2027 as compared to the previous year.
The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
Growth Indicators
According to the World Health Organization (WHO), the global cardiovascular disease death burden is estimated to reach 17.9 million in the year 2016.
Prevalence of cardiovascular diseases can be linked due to several behavioral factors, which includes consumption of tobacco, alcohol or an unhealthy diet. Additionally, other factors such as high blood pressure and obesity can also be attributed for the increasing cases of heart attacks and other CVD diseases. Moreover, the aging population are always prone to these types of diseases. Apparently, the growing medical device industry, along with the advancements observed in the treatment procedures and the increasing concern for the incidences of cardiovascular disorders amongst individuals around the globe are some of the factors anticipated to drive the growth of the global percutaneous coronary intervention market.
Barriers
High risk of infection in patients post utilization of percutaneous coronary intervention and interventional heart disease procedures, which has raised the concern amongst individuals, along with lack of availability of skilled professionals are some of the factors anticipated to hamper the growth of the global percutaneous coronary intervention market.
Some of the affluent industry leaders in the global percutaneous coronary intervention market are Abbott, Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, B. Braun Melsungen AG, Getinge AB, Terumo Corporation, Asahi Intecc Co., Ltd., Becton, Dickinson and Company and Biosensors International Group, Ltd.
January 2019: Abbott announced the FDA approval of TactiCathÔ Contact Force Ablation Catheter, Sensor Enabled™ for the accurate and effective treatment of patients suffering from atrial fibrillation.
September 2019: Boston Scientific Corporation declared that it got positive outcomes from the EVOLVE Short DAPT clinical trial by the utilization of SYNERGYÔ Bioabsorbable Polymer (BP) Stent on patients with an increased risk of bleeding.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Increasing incidence of cardiovascular disorders, along with the increasing geriatric population are some of the major factors that are driving the growth of the market.
Ans: The market is anticipated to attain a CAGR of 5.39% over the forecast period, i.e. 2020-2027.
Ans: With the presence of nations, such as UK, Spain, Germany and France, Europe is anticipated to provide more business opportunities for the growth of the market in the future.
Ans: The major players in the global percutaneous coronary intervention market are Abbott, Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, B. Braun Melsungen AG, Getinge AB, Terumo Corporation, Asahi Intecc Co., Ltd., Becton, Dickinson and
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is majorly segmented by product, end users and by region.
Ans: The coronary stents segment, which is a sub-segment of the product segment, held the largest market share of 53.84% in the year 2018, is anticipated to show significant growth opportunity in the percutaneous coronary intervention market.
Ans: High risk of infection in patients along with lack of availability of skilled professionals are some of the major factors anticipated to act as a barrier towards the growth of the global percutaneous coronary intervention market.
Submit Your Request For Proposal (RFP)
